quadruplet therapies for treating mm: the current evidence and the findings of a phase ii trial
Published 9 months ago • 262 plays • Length 9:57Download video MP4
Download video MP3
Similar videos
-
3:46
a phase ib/ii trial of sonrotoclax plus dexamethasone in patients with r/r mm harboring t(11;14)
-
2:16
the impact of autosct on disease burden in patients with myeloma treated with quadruplet therapy
-
2:17
extended follow-up of the master trial
-
2:17
advancements in quadruplet regimens for the treatment of multiple myeloma
-
1:03
quadruplet regimens for patients with transplant-ineligible multiple myeloma
-
1:41
quadruplet induction therapy as a new standard of care in multiple myeloma
-
0:38
pain management for patients with scd and thalassemia in lebanon
-
2:16
quadruplet therapy with and without autohsct in ndmm
-
3:40
the mutagenic impact of radiotherapy & chemotherapy in multiple myeloma and lymphoma
-
1:01
an update on the phase i trial of bms-986393, a novel gprc5d-targeted car-t, in r/r myeloma
-
1:15
the current status and future of car-t therapy in r/r myeloma
-
1:05
optimizing the treatment of transplant-eligible ndmm: using quadruplets in induction & consolidation
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
2:17
session highlights: practical aspects of immunotherapy in multiple myeloma
-
5:19
the current treatment landscape for multiple myeloma and trials investigating novel combinations
-
1:53
the future of multiple myeloma treatment
-
4:10
treatment-free intervals for patients with myeloma
-
3:26
new approaches to treating transplant-ineligible multiple myeloma: triplets and quadruplets